Cotransplantation of haploidentical mesenchymal stem cells to reduce the risk of graft failure in a patient with refractory severe aplastic anemia

Acta Haematologica

Volumn 119, Issue 3, 2008, Pages 162-165

  Fang, Baijun ^a   Song, Yongping ^a   Li, Ning ^a   Li, Jing ^b   Zhao, Robert Chunhua ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; OKT 3; THYMOCYTE ANTIBODY;

ANAPHYLAXIS; APLASTIC ANEMIA; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; CASE REPORT; DISEASE SEVERITY; FEMALE; GRAFT FAILURE; GRAFT REJECTION; HAPLOTYPE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKAPHERESIS; MESENCHYMAL STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; REFRACTORY ANEMIA; RISK REDUCTION; SCHOOL CHILD; THROMBOCYTE TRANSFUSION;

ADULT; ANAPHYLAXIS; ANEMIA, REFRACTORY; CELLS, CULTURED; CHILD; COMBINED MODALITY THERAPY; FEMALE; GRAFT REJECTION; HEMATOPOIETIC STEM CELL MOBILIZATION; HISTOCOMPATIBILITY; HUMANS; IMMUNOSUPPRESSION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECURRENCE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 46049114888     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000134015     Document Type: Article

References (8)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
2. Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR Jr, Moseley AB, Bacigalupo A: Co-transplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005;11:389-398.
3. Fang B, Song Y, Lin Q, Zhang Y, Cao Y, Zhao RC, Ma Y: Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children. Pediatr Transplant 2007;11:814-817.
4. Fang B, Song YP, Liao LM, Han Q, Zhao RC: Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells. Bone Marrow Transplant 2006;38:389-390.
5. Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, Egeler RM, Locatelli F, Fibbe WE: Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 2007;110:2764-2767.
6. Le Blanc K, Samuelsson H, Gustafsson B, Remberger M, Sundberg B, Arvidson J, Ljungman P, Lönnies H, Nava S, Ringdén O: Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 2007;21:1733-1738.
7. Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM, Santos G, Gordon-Smith EC, Storb R: A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1979;53:504-514.
8. Cao Y, Sun Z, Liao L, Meng Y, Han Q, Zhao RC: Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 2005;332:370-379.